Connect your AI

Cytek Biosciences, Inc. CTKB Segment Reporting Other Item Amount

Segment Reporting Other Item Amount at other companies

CONMEDCNMD

$6.23M+6.4%

Century CommunitiesCCS

$22.22M+279%

EyePoint, Inc. EYPT

$4.06M+16.7%

Essential UtilitiesWTRG

-$75K+74.4%

Radiant LogisticsRLGT

-$271K-113%

Equitable HoldingsEQH

$371M-5.1%

Segments

By segment

Reportable Segment$403K+111%

Other financials

Income statement

Revenue$44.1M+6.5%

Gross profit$21.3M+5.4%

Operating income-$18.5M-23.3%

Net income-$18.9M-65.5%

EPS (diluted)-$0.15-66.7%

Balance sheet

Cash & equivalents$31.8M-66.6%

Total debt$16.8M+40.9%

Total equity$327.6M-13.7%

Total assets$449.1M-6.9%

Cash flow

Operating cash flow-$2.7M-2,089%

CapEx$2.2M+155%

Free cash flow-$4.9M-403%

Valuation

Market cap$577.27M+54.5%

Enterprise value$562.23M+93.7%

P/S2.8×+0.9×

Profitability

Gross margin51.7%-3.2pp

Operating margin-21.5%—

Net margin-36.2%—

FCF margin-6.2%-15.1pp

Returns & leverage

Return on equity-20.9%—

Debt / equity0.1×0.0×

Current ratio4.7×-0.9×